Skip to main content
. 2017 Mar 14;8(22):36339–36353. doi: 10.18632/oncotarget.16193

Figure 3. Hazard ratios (95% credential intervals) of overall survival in 3 years and 5 years for network comparison of EC treatments.

Figure 3